Skip to main content
SpringerLink
Log in

Mycobacterial Antimicrobial Resistance

  • Chapter
Antimicrobial Resistance and Implications for the Twenty-First Century

Part of the book series: Emerging Infectious Diseases of the 21 Century ((EIDC))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abate, G., (2002), Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Ethiopian Med J, 40, 79–86.

    Google Scholar 

  • Abe, C. and Abu, A.K.K., (2002), Status of antituberculosis drug resistance in Saudi Arabia 1979–98. East Mediterranean Hlth J, 8, 664–670.

    Google Scholar 

  • Aberg, J.A., Wong, M.K., Flamm, R., Notario, G.F. and Jacobson, M.A., (2001), Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. HIV Clin Trials, 2, 453–459.

    PubMed  CAS  Google Scholar 

  • Adegbola, R.A., Hill, P., Baldeh, I., Out, J., Sarr, R., Sillah, J., Lienhardt, C., Corrah, T., Manneh, K., Drobniewski, F. and McAdam, K.P.J.W., (2003), Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis, 7, 390–393.

    PubMed  CAS  Google Scholar 

  • Al-Marri, M.R., (2001), Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Int J Tuberc Lung Dis, 5, 1116–1121.

    PubMed  CAS  Google Scholar 

  • American Thoracic Society, (1994), Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med, 149, 1359–1374.

    Google Scholar 

  • American Thoracic Society, (1997), Diagnosis and treatment of diseases caused by nontuberculous mycobacteria. Am J Respir Crit Care Med, 156, S1–S25.

    Google Scholar 

  • Augustynowicz, K.E., Zwolska, Z., Jaworski, A., Kostrzewa, E. and Klatt, M., (2003), Drug-resistant tuberculosis in Poland in 2000: second national survey and comparison with the 1997 survey. Int J Tuberc Lung Dis, 7, 645–651.

    Google Scholar 

  • Balabanova, Y., Ruddy, M., Hubb, J., Yates, M., Malomanova, N., Fedorin, I. and Drobniewski, F., (2005), Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis 24, 136–139.

    PubMed  CAS  Google Scholar 

  • Banks, J. and Campbell, I., (2003), Environmental mycobacteria. In P.D.O. Davies, editor, Clinical Tuberculosis. London, Arnold, pp. 439–448.

    Google Scholar 

  • Baylan, O., Kisa, O., Albay, A. and Doganci, L., (2004), Evaluation of a new automated, rapid colormetric culture system using solid medium for laboratory diagnosis of tuberculosis and determination of anti-tuberculosis drug susceptibility. Int J Tuberc Lung Dis, 8, 772–777.

    PubMed  CAS  Google Scholar 

  • Breathnach, A.S., de Ruiter, A., Holdsworth, G.M., Bateman, N.T., O’Sullivan, D.G., Rees, P.J., Snashall, D., Milburn, H.J., Peters, B.S., Watson, J., Drobniewski, F.A. and French, G.L., (1998), An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect, 92, 111–117.

    Google Scholar 

  • Brennan, P.J. and Draper, P., (1994), Ultrastructure of Mycobacterium tuberculosis: In Bloom, E.R., editor, Tuberculosis: Pathogenesis, Protection and Control. Washington, DC, American Society for Microbiology, pp. 271–284.

    Google Scholar 

  • Butt, T., Ahmad, R.N., Kazmi, S.Y. and Rafi, N., (2004), Multi-drug resistant tuberculosis in Northern Pakistan. J Pak Med Assoc, 54, 469–472.

    PubMed  CAS  Google Scholar 

  • Caminero, J.A., (2005), Management of multidrug resistant tuberculosis and patients in retreatment. Eur Respir J, 25, 928–936.

    PubMed  CAS  Google Scholar 

  • Centres for Disease Control and Prevention, (1992), Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system: New York, 1991. MMWR Morb Mortal Wkly Rep, 41 (28), 507–509.

    Google Scholar 

  • Centres for Disease Control and Prevention, (1993), Outbreak of multidrug-resistant tuberculosis at a hospital: New York City, 1991. MMWR Morb Mortal Wkly Rep, 42 (22), 427, 433–434.

    Google Scholar 

  • Centres for Disease Control and Prevention, (2005), National plan for reliable tuberculosis laboratory services using a systems approach: recommendations from CDC and the Association of Public Health Laboratories. Task Force on Tuberculosis Laboratory Services. MMWR Morb Mortal Wkly Rep, 54 [RR-6], 1–12.

    Google Scholar 

  • Chan, E.D., Laurel, V., Strand, M.J., Chan, J.F., Huynh, M.L.N., Goble, M. and Iseman, M.D., (2004), Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med, 169, 1103–1109.

    PubMed  Google Scholar 

  • Chiang, Y.C., Hsu, C.J., Huang, M.R., Lin, P.T. and Luh, K.T., (2004), Antituberculosis drug resistance among retreatment tuberculosis patients in a referral centre in Taipei. J Formosa Med Assoc, 103, 411–541.

    Google Scholar 

  • Condos, R., Rom, W.N. and Schluger, N.W., (1997), Treatment of multidrug-resistant pulmonary tuberculosis with interferon-g via aerosol. Lancet, 349, 1513–1515.

    PubMed  CAS  Google Scholar 

  • Conover, C., Ridzon, R., Valway, S., Schoenstadt, L., McAuley, J., Onorato, I. and Paul, W., (2001), Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis, 1, 59–64.

    Google Scholar 

  • Coronado, V.G., Beck-Sague, C.M., Hutton, M.D., Davis, B.J., Nicholas, P., Villareal, C., Woodley, C.L., Kilburn, J.O., Crawford, J.T. and Frieden, T.R., (1993), Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis, 1684, 1052–1055.

    Google Scholar 

  • Cox, H.S., Orozco, J.D., Male, R., Ruesch, G.S., Falzon, D., Small, I., Doshetov, D., Kebede, Y. and Aziz, M., (2004), Multidrug-resistant tuberculosis in central Asia. Emerg Infect Dis, 10, 865–872.

    PubMed  Google Scholar 

  • Craft, J.C., Notario, G.F., Grosset, J.H. and Heifets, L.B., (1998), Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS. Clin Infect Dis, 27, 807–812.

    PubMed  CAS  Google Scholar 

  • Cynamon, M.H., Klemens, S.P., Sharpe, C.A. and Chase, S., (1999), Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model. Antimicrob. Agents Chemother, 43, 1189–1191.

    PubMed  CAS  Google Scholar 

  • Daikos, G.L., Cleary, T., Rodriguez, A. and Fischl, M.A., (2003), Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis, 7, 394–398.

    PubMed  CAS  Google Scholar 

  • David, H.L., Jahan, M.T., Jumin, J., Grandry, J. and Lehman, E.H., (1978), Numerical taxonomy analysis of Mycobacterium africanum. Int J Syst Bacteriol, 28, 464–472.

    Google Scholar 

  • Davies, L. and Davies, P.D.O., (1995), Non-tuberculosis mycobacterial infections: no fire without a smoke. Am J Respir Crit Care Med, 151, A7I5.

    Google Scholar 

  • Davies, P.D.O., (1994), Infection with Mycobacterium kansasii. (Editorial). Thorax, 49, 435–436.

    PubMed  CAS  Google Scholar 

  • Deivanayagam, C.N., Rajasekaran, S., Venkatesan, S., Mahilmaran, A., Ahmed, P.R.K., Annadurai, S., Kumar, S., Chandrasekar, C., Ravichandran, N. and Pencillaiah, R., (2002), Ind J Chest Dis Allied Sci, 44, 237–242.

    Google Scholar 

  • De Riemer, K., Garcia, G.L., Bobadilla-del-Valle, M., Palacios, M.M., Martinez, G.A., Small, P.M., Sifuentes, O.J. and Ponce-de-Leon, A., (2005), Does DOTS work in populations with drug-resistant tuberculosis? Lancet, 365, 1239–1245.

    Google Scholar 

  • Dewan, P., Sosnovskaja, A, Thomsen, V., Cicenaite, J., Laserson, K., Johansen, I., Davidaviciene, D. and Wells, C., (2005), High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002. Int J Tuberc Lung Dis, 9, 170–174.

    PubMed  CAS  Google Scholar 

  • Drobniewski, F.A., (1997), Is death inevitable with multiresistant TB plus HIV infection? Lancet, 349, 71–72.

    PubMed  CAS  Google Scholar 

  • Drobniewski, F.A., Caws, M., Gibson, A. and Young, D., (2003), Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis, 3, 141–147.

    PubMed  CAS  Google Scholar 

  • Drobniewski, F.A., Watterson, S.A., Wilson, S.M. and Harris, G.S., (2000), A clinical, microbiological and economic analysis of national service for the rapid diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol, 49, 271–278.

    PubMed  CAS  Google Scholar 

  • Durek, C., Richter, E., Basteck, A., Rüsch-Gerdes, R., Gerdes, J., Jocham, D. and Bohle, A., (2001), The fate of bacillus Calmette-Guerin after intravesical instillation. J Urol, 165, 1765–1768.

    PubMed  CAS  Google Scholar 

  • Dye, (2002), J. Infect Dis, 185, 1197–1202.

    Google Scholar 

  • Evans, S.A., Colville, A., Evans, A.L., Crisp A.L. and Johnston, I.D.A., (1996), Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax, 51, 1248–1252.

    PubMed  CAS  Google Scholar 

  • Friedland, J.S., (2004), Tuberculosis. In J. Cohen, W.G. Powderly, editors, Infectious Diseases, 2nd Edition, Volume 1. New York, Mosby, pp. 401–418.

    Google Scholar 

  • Gale, E.F., Cundliff, E., Reynolds, P.E., Richmond, M.H., Waring, M.J., (1981), The Molecular Basis of Antibiotic Action, 2nd Edition. New York, Wiley.

    Google Scholar 

  • Giosue, S., Casarini, M., Ameglio, F., Zangrilli, P., Palla, M., Attieri, A.M. and Bisette, A., (2000), Aerosolized interferon-alpha treatment in patients with multidrug-resistant pulmonary tuberculosis. Eur Cytokine Netw, 11, 99–104.

    PubMed  CAS  Google Scholar 

  • Goble, M., Iseman, M.D., Madsen, L.A., Waite, D., Ackerson, L. and Horsburgh, C.R, (1993), Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med, 328, 527–532.

    PubMed  CAS  Google Scholar 

  • Grosskinsky, C.M., Jacobs, W.R., Jr, Clark-Curtiss, J.E. and Bloom, B.R., (1989), Genetic relationships among Mycobacterium tuberculosis and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence. Infect Immun, 57, 1535–1541.

    PubMed  CAS  Google Scholar 

  • Hannan, M.M., Peres, H., Maltez, F., Hayward, A.C., Machado, J., Morgado, A., Proenca, R., Nelson, M.R., Bico, J., Young, D.B. and Gazzard, B.S., (2002), Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect, 72, 91–97.

    Google Scholar 

  • Hayward, A.C., Bennett, D.E., Herbert. J. and Watson, J.M., (1996), Risk factors for drug resistance in patients with tuberculosis in England and Wales 1993–4. Thorax, 51(Suppl 3), S32.

    Google Scholar 

  • Hillemann, D., Weizenegger, M., Kubica, T., Richter, E. and Niemann, S., (2000), Use of genotype DNA MTBDR assay for the rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect, 2, 659–669.

    Google Scholar 

  • Hillemann, D., Weizenegger, M., Kubica, T., Richter, E. and Niemann, S., (2005), Use of genotype MTB DR assay for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol, 43, 3699–3703.

    PubMed  CAS  Google Scholar 

  • Hirano, K., Wada, M. and Aoyagi, T., (2001), Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997. Int J Tuberc Lung Dis, 5, 46–52.

    PubMed  Google Scholar 

  • Holland, S.M., Eisenstein, E.M., Kuhns, D.B., Turner, M.L., Fleisher, T.A., Strober, W. and Gallin, J.I., (1994), Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon-gamma: a preliminary report. N Engl J Med, 330, 1348–1355.

    PubMed  CAS  Google Scholar 

  • Hong Kong Chest Service/British Medical Research Council, (1981), First report: controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet, 1, 171–174.

    Google Scholar 

  • Hong Kong Chest Service/British Medical Research Council, (1982), Second report: controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months. The results up to 24 months. Tubercle, 63, 89–98.

    Google Scholar 

  • Hong Kong Chest Service/British Medical Research Council, (1987), Five year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis, 136, 1339–1342.

    Google Scholar 

  • Hong Kong Chest Service/British Medical Research Council, (1991), Controlled trial of 2, 4 and 6 months of pyrazinamide in 6 month, three-times weekly regimens for smear-positive tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide. Results at 30 months. Am Rev Respir Dis, 143, 700–706.

    Google Scholar 

  • Iseman, M., (1993), Treatment of multidrug resistant tuberculosis. N Engl J Med, 329, 784–790.

    PubMed  CAS  Google Scholar 

  • Jacobs, W.R., Jr, Barletta, R.G., Udani, R., Chan, J., Kalkut, G., Sosne, G., Kieser, T., Sarkis, G.J., Hatfull, G.F. and Bloom, B.R., (1993), Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reported phages, Science, 260, 819–822.

    PubMed  CAS  Google Scholar 

  • Johansen, I.S., Lundgern, B., Sosnovskaja, A. and Thomsen, V.O., (2003), Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low-and high-incidence countries by line probe assay. J Clin Microbiol, 41, 4454–4456.

    PubMed  CAS  Google Scholar 

  • Johansen, I.S., Thomsen, V.O., Marjamäkj, M., Sosnovskaja, A. and Lungern, B., (2004), Rapid, automated, non-radiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line anti-tuberculous drugs used in standard short-course chemotherapy. Diagn Microbiol Infect Dis, 50, 103–107.

    PubMed  CAS  Google Scholar 

  • Johnson, B.J., Bekker, L.G., Rickman, Brown, S., Lesser, M., Ress, S., Willcox, P., Steyn, L. and Kaplan, G., (1997), rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. Tuber Lung Dis, 78, 195–203.

    PubMed  CAS  Google Scholar 

  • Joint Tuberculosis Committee of the British Thoracic Society, (1998), Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax, 53, 536–548.

    Google Scholar 

  • Joint Tuberculosis Committee of the British Thoracic Society, (2000), Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax, 55, 887–901.

    Google Scholar 

  • Juréen, P., Warngren, J. and Hoffner, S.E., (2004), Evaluation of the line probe assay (Li PA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis, 84, 311–316.

    PubMed  Google Scholar 

  • Kam, K.M. and Yip, C.W., (2004), Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995–2002, after the implementation of DOTS-plus. Int J Tuberc Lung Dis, 8, 760–766.

    PubMed  CAS  Google Scholar 

  • Kartaloglu, Z., Bozkanat, E., Ozturkeri, H., Okutan, O. and Ilvan, A., (2002), Primary antituberculosis drug resistance at Turkish military chest diseases hospital in Istanbul. Med Princ Pract, 11, 202–205.

    PubMed  Google Scholar 

  • Kassa, K.E., Bobossi, S.G., Takeng, E.C., Nambea, K.T.B., Yapou, F. and Talarmin, A., (2004), Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis, 8, 574–578.

    Google Scholar 

  • Kelly, P.M., Scott, L. and Krause, V.L., (2002), Tuberculosis in East Timorese refugees: implications for health care needs in East Timor. Int J Tuberc Lung Dis, 6, 980–987.

    PubMed  CAS  Google Scholar 

  • Kim, H.C., Goo, M.J., Lee, H.J., Park, H.S., Park, M.C., Kim, T.J. and Im, J.G., (2004), Multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in human immunodeficiency virus-negative patients: computed tomography features. J Comput Assist Tomogr, 28, 366–371.

    PubMed  Google Scholar 

  • Kimerling, M.E., Schuchter, J, Chanthol, E., Kunthy, T., Stuer, F., Glaziou, P. and Ee, O., (2002), Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis, 6, 988–994.

    PubMed  CAS  Google Scholar 

  • Kisa, O., Abley, A., Bedir, O., Baylon, O. and Doganci, L., (2003), Evaluation of FAST Plaque to TB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis, 7, 284–288.

    PubMed  CAS  Google Scholar 

  • Kochi, A., Vareldzis, B. and Styblo, K., (1993), Multidrug-resistant tuberculosis and its control. Res Microb, 144, 104–110.

    CAS  Google Scholar 

  • Konno, K., Feldmann, F.M. and McDermott, W., (1967), Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis, 95, 461–469.

    PubMed  CAS  Google Scholar 

  • Krishnamurthy, A., Rodriques, C. and Mehta, A.P., (2002), Rapid detection of rifampicin resistance in M. tuberculosis by phage assay. Ind J Med Microbiol, 20, 211–214.

    CAS  Google Scholar 

  • Lee, J. and Chang, J.H., (2001), Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Kor J Int Med, 16, 173–179.

    CAS  Google Scholar 

  • Lefford, M.J., (1966), The ethionamide sensitivity of British pre-treatment strains of Mycobacterium tuberculosis. Tubercle Lond, 47, 198–206.

    CAS  Google Scholar 

  • Leimane, V., Riekstina, V., Holtz, T.H., Zarovska, E., Skripconoka, V., Thorpe, L.E., Laserson, K.F. and Wells, C.D., (2005), Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet, 365, 318–326.

    PubMed  Google Scholar 

  • Levin, M.E. and Hatfull, G.F., (1993), Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol Microbiol, 8, 277–285.

    PubMed  CAS  Google Scholar 

  • Levy-Frebault, V.V. and Portaels, F., (1992), Proposed minimal standards for the genus Mycobacteria and the description of new slowly growing Mycobacterium species. Int J Syst Bacteriol, 42, 315–323.

    PubMed  CAS  Google Scholar 

  • Li, J., Burzynski, J.N., Lee, Y.A., Berg, D., Driver, R.C., Ridzon, R. and Munsiff, S.S., (2004), Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients. Chest, 126, 1770–1776.

    PubMed  Google Scholar 

  • Lin, J., Sattar, A.N. and Puckree, T., (2004), An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. Int J Tuberc Lung Dis, 8, 568–573.

    PubMed  CAS  Google Scholar 

  • Lockman, S., Kruuner, A., Binkin, N., Levina, K., Wang, Y., Danilovitsh, M., Hoffner, S. and Tappero, J., (2003), Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Clin Infect Dis, 32, 373–380.

    Google Scholar 

  • Mahmoudi, A. and Iseman, M.D., (1993), Pitfalls in the care of patients with tuberculosis. JAMA, 270, 65–68.

    PubMed  CAS  Google Scholar 

  • Maloney, S.A., Pearson, M.L., Gordon, M.T., Del Castillo, R., Boyle, J.F. and Jarvis, W.R., (1995), Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med, 122, 90–95.

    PubMed  CAS  Google Scholar 

  • Marín, M., de Viedma, D.G., Ruiz-Serrano, M.J. and Bouza, E., (2004), Rapid detection of multiple rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real time PCR. Antimicrob Agents Chemother, 48, 4293–4300.

    PubMed  Google Scholar 

  • Mortilla, H. J., Soini, H., Vyshnevskiy, B. I., Otten, T.F., Vasilyef, A.V., Huovinen, P. and Viljanen, M.K., (1998), Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis, 30, 129–132.

    Google Scholar 

  • McClure, W.R. and Cech, C.L., (1978), On the mechanism of rifampicin inhibition if RNA synthesis. J Biol Chem, 253, 8949–8956.

    PubMed  CAS  Google Scholar 

  • Mitchell, I., Wendon, J., Fi, H.S. and Williams, R., (1995), Anti-tuberculous therapy and acute liver failure. Lancet, 345, 555–556.

    PubMed  CAS  Google Scholar 

  • Mitchison, D.A. and Nunn, A.J., (1986), Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis, 133, 423–430.

    Google Scholar 

  • Migliori, G.B., Raviglione, M.C., Schaberg, T., Davies, P.D.O., Zellweger, J.P., Grzemska, M., Mihaescu, T., Clancy, L. and Casali, L., (1999), Tuberculosis management in Europe. Eur Respir J, 14, 978–992.

    PubMed  CAS  Google Scholar 

  • Mokrousov, L.O., Narvskaya, T., Otten, T., Limeshenke, E., Steklova, L. and Vyshnevskiy, B., (2002), High prevalence of katG Ser 315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia 1996 to 2001. Antimicrob Agents Chemother, 46, 1417–1424.

    PubMed  CAS  Google Scholar 

  • Moro, M.L., Errante, I., Infuso, A., Sodano, L., Gori, A., Orcese, C.A., Salamina, G., D’Amico, C., Besozzi, G. and Caggese, L., (2000), Effectiveness of infection control measures in controlling a nosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy. Int J Tuberc Lung Dis, 41, 61–68.

    Google Scholar 

  • Moro, M.L., Gori, A., Errante, I., Infuso, A., Franzetti, F., Sodano, L. and Iemoli, E., (1998), An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS, 129, 1095–1102.

    Google Scholar 

  • Mukherjee, J.S., Joseph, J.K., Rich, M.L., Shin, S.S., Furin, J.J., Seung, K.J., Sloutsky, A., Socci, A.R., Vanderwarker, C., Vasquez, L., Palacios, E., Guerra, D., Viru, F.A., Farmer, P. and Del-Castillo, H.E., (2003), Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis, 7, 637–644.

    PubMed  CAS  Google Scholar 

  • Oleksijew, A., Meulbroek, J., Ewing, P., Jarvis, K., Mitten, M., Paige, L., Tovcimak, A., Nukkula, M., Chu, D. and Alder, J.D., (1998), In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains. Antimicrob Agents Chemother, 42, 2674–2677.

    PubMed  CAS  Google Scholar 

  • Pablos-Mendez, A. and Lessnau, K., (2000), Clinical mismanagement and other factors producing antituberculosis drug resistance. In I. Bastian and F. Portaels, editors, Multidrug-resistant Tuberculosis. Dordrecht, Kluwer, pp. 59–76.

    Google Scholar 

  • Palmero, D., Ritacco, V., Ambroggi, M., Marcela, N., Barrera, L., Capone, L., Dambrosi, A., di-Lonardo, M., Isola, N., Poggi, S., Vescovo, M. and Abbate, E., (2003), Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg Inf Dis, 9, 965–969.

    Google Scholar 

  • Park, S.K., Lee, C.M., Heu, J.P. and Song, S.D., (2002), A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 6, 143–149.

    PubMed  CAS  Google Scholar 

  • Petrie, J.G., Barnwell, E. and Grimshaw, J., (1995), on behalf of the Scottish InterCollegiate Guidelines Network. Clinical Guidelines: Criteria for Appraisal for National Use. Edinburgh: Royal College of Physicians.

    Google Scholar 

  • PHLS (1999) Tuberculosis Update. Public Health Laboratory Service Communicable Disease Surveillance Centre. December 1999.

    Google Scholar 

  • Piatek, A.S., Telenti, A., Murray, M.R., El-Hajj, H. and Jacobs, W.R., Jr., (2000), Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother, 44, 103–110.

    PubMed  CAS  Google Scholar 

  • Pierce, M., Crampton, S., Henry, D., Heifets, L., LaMarca, A., Montecalvo, M., Wormser, G.P., Jablonowski, H., Jemsek, J., Cynamon, M., Yangco, B.G., Notario, G. and Craft, J.C., (1996), A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med, 335, 384–391.

    PubMed  CAS  Google Scholar 

  • Pitchenik, A.E., Burr, J., Laufer, M., Miller, G., Cacciatore, R., Bigler, W.J., Witte, J.J. and Cleary, T., (1990), Outbreaks of drug-resistant tuberculosis at AIDS centre. Lancet, 336, 440–441.

    PubMed  CAS  Google Scholar 

  • Pomerantz, B.J., Cleveland, J.C., Olson, H.K. and Pomerantz, M., (2001), Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg, 121, 448–453.

    PubMed  CAS  Google Scholar 

  • Punnotok, J., Shaffer, N., Naiwatanakul, T., Pumprueg, U., Subhannachart, P., Ittiravivongs, A., Chuchotthaworn, C., Ponglertnapagorn, P., Chantharojwong, N., Young, N.L., Limpakarnjanarat, K. and Mastro, T.D., (2000), Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis, 4, 537–543.

    PubMed  CAS  Google Scholar 

  • Quy, H.T.W., Lan, N.T.N., Borgdorff, M.W., Grosset, J., Linh, P.D., Tung, L.B., van-Soolingen, D., Raviglione, M., Co, N.V. and Broekmans, J., (2003), Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis, 7, 631–636.

    PubMed  CAS  Google Scholar 

  • Ramaswamy, S. and Musser, J.M., (1998), Molecular genetic-basis of antimicrobial agent resistance in Mycobacterium tuberculosis, 1998 update. Tuber Lung Dis, 79, 3–29.

    PubMed  CAS  Google Scholar 

  • Romano, G., Michell, P., Pacilio, C. and Giordano, A., (2000), Latest development in gene transfer technology, achievements, perspectives and controversies over therapeutic applications. Stem Cells, 18, 19–39.

    PubMed  CAS  Google Scholar 

  • Rosner, J.L., (1993), Susceptibilities of oxyR regulon mutants of Escherchia coli and Salmonella typhimurium to isoniazid. Antimicrob Agents Chemother, 37, 2251–2253

    PubMed  CAS  Google Scholar 

  • Rossau, R., Traore, H., De Beenhouwer, H., Mijs, W., Jannes, G., de Rijk, P. and Portaels, F., (1997), Evaluation of the INNO-LIPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother, 41, 2093–2098.

    PubMed  CAS  Google Scholar 

  • Ruddy, M., Balabanova, Y., Graham, C., Fedorin, I., Malomanova, N., Elisarova, E., Kuznetznov, S., Gusarova, G., Zakharova, S., Melentyev, A., Krukova, E., Golishevskaya, V., Erokhin, V., Dorozhkova, I. and Drobniewski, F., (2005), Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax, 60, 130–135.

    PubMed  CAS  Google Scholar 

  • Reechaipichitkul, W., (2002), Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J Trop Med Pub Hlth, 33, 570–574.

    Google Scholar 

  • Robert, J., Trystram, D., Truffot, P.C. and Jarlier, V., (2003), Multidrug-resistant tuberculosis, eight years of surveillance in France. Eur Respir J, 22, 833–837.

    PubMed  CAS  Google Scholar 

  • Salaniponi, F.M., Nyirenda, T.E., Kemp, J.R., Squire, S.B., Godfrey-Faussett, P. and Harries, A.D., (2003), Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. Int J Tuberc Lung Dis, 7, 948–952.

    PubMed  CAS  Google Scholar 

  • Scarparo, C., Ricordi, P., Ruggiero, G. and Piccoli, P., (2004), Evaluation of the fully Automated BACTEC MGIT 960 system for testing susceptibility to Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampicin and ethembutol and comparison with the Radiometric BACTEC 460 TB method. J Clin Microbiol, 42, 1109–1114.

    PubMed  CAS  Google Scholar 

  • Schaaf, H.S., Shean, K. and Donald, P.R., (2003), Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child, 88, 1106–1111.

    PubMed  CAS  Google Scholar 

  • Schneider, E., Laserson, K.F., Wells, C.D. and Moore, M., (2004), Tuberculosis along the United States–Mexico border, 1993–2001. Rev Panam Salud Pub, 16, 23–34.

    Google Scholar 

  • Schraufnagel, D.E., (1999), Tuberculosis treatment for the beginning of the next century. Int J Tuberc Lung Dis, 3, 651–662.

    PubMed  CAS  Google Scholar 

  • Senaratne, W.V., (2004), Outcome of treatment of multidrug resistant tuberculosis. Ceylon Med J, 49, 86–87.

    PubMed  CAS  Google Scholar 

  • Shafer, R.W., Small, P.M., Larkin, C., Singh, S.P., Kelly, P., Sierra, M.F., Schoolnik, G. and Chirgwin, K.D., (1995), Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment. J Infect Dis, 171, 170–176.

    PubMed  CAS  Google Scholar 

  • Shafran, S.D., (1998), Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. Int J Infect Dis, 3, 39–47.

    PubMed  CAS  Google Scholar 

  • Shafran, S.D., Talbot, J.A., Chomyc, S., Davison, E., Singer, J., Phillips, P., Salit, I., Walmsley, S.L., Fong, I.W., Gill, M.J., Rachlis, A.R. and Lalonde, R.G., (1998), Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. Clin Infect Dis, 27, 1401–1405.

    PubMed  CAS  Google Scholar 

  • Shah, A.R., Agarwal, S.K. and Shah, K.V., (2002), Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc Lung Dis, 6, 1098–1010.

    PubMed  CAS  Google Scholar 

  • Shin, S., Furin, J., Bayona, J., Mate, K., Kim, J.Y. and Farmer, P., (2004), Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med, 59, 1529–1539.

    PubMed  Google Scholar 

  • Shiraishi, Y., Nakajima, Y., Katsuragi, N., Kurai, M. and Takahashi, N., (2004), Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. J Thorac Cardovasc Surg, 128, 523–528.

    Google Scholar 

  • Slayden, R.A., Barry, C.E., 3rd, (2000), The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect, 2, 659–669.

    PubMed  CAS  Google Scholar 

  • Small, P.M., Shafer, R.W., Hopewell, P.C., Singh, S.P., Murphy, M.J., Desmond, E., Sierra, M.F. and Schoolnik, G.K., (1993), Exogenous re-infection with multi-drug resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med, 328, 1137–1144.

    PubMed  CAS  Google Scholar 

  • Sreevatson, S., Pan, X., Zhang, Y., Deretic, V. and Musser, J.M., (1997), Analysis of the oxyR–ahpC region in isoniazid-resistant and susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother, 41, 600–606.

    Google Scholar 

  • Stanford, J.L., Stanford, C.A., Grange, J.M., Lan, N.N. and Etemadi, A., (2001), Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multidrug-resistant pulmonary tuberculosis? Respir Med, 95, 444–447.

    PubMed  CAS  Google Scholar 

  • Stover, C.K., Warrener, P., Van Devanter, D.R., Sherman, D.R., Arain, T.M., Langhorne, M.H., Anderson, S.W., Towell, J.A., Yuan, Y., McMurray, D.N., Kreiswirth, B.N., Barry, C.E. and Baker, W.R., (2000), A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 405, 962–966.

    PubMed  CAS  Google Scholar 

  • Stroud, L.A., Tokars, J.I., Grieco, M.H., Crawford, J.T., Culver, D.H., Edlin, B.R., Sordillo, E.M., Woodley, C.L., Gilligan, M.E. and Schneider, N., (1995), Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol, 3, 141–147.

    Google Scholar 

  • Suarez, S., O’Hara, P., Kazantseva, M., Newcomer, C.E., Hopfer, R., McMurray, D.N., Hickey, A.J., (2001), Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother, 48, 431–434.

    PubMed  CAS  Google Scholar 

  • Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society, (2000), Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax, 55, 210–218.

    Google Scholar 

  • Syre, H., Phyu, S., Sandven, P., Bjorvatn, B. and Grewd, H.M.S., (2003), Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampicin in liquid cultures. J Clin Microbiol, 41, 5173–5177.

    PubMed  CAS  Google Scholar 

  • Talbot, E.A., Kenyon, T.A., Mwasekaga, M.J., Moeti, T.L., Mallon, V. and Binkin, N.J., (2003), Control of anti-tuberculosis drug resistance in Botswana. Int J Tuberc Lung Dis, 7, 72–77.

    PubMed  CAS  Google Scholar 

  • Telenti, A., Honoré, N., Bernasconi, J., March, J., Ortega, A., Heym, B., Takiff, H.E. and Cole, S.T., (1997), Genotyping assessment of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol, 35, 719–723.

    PubMed  CAS  Google Scholar 

  • Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. and Bodmer, T., (1993), Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647–650.

    PubMed  CAS  Google Scholar 

  • Telzak, E.E., Sepowitz, K., Alpert, P., Mannheimer, S., Medard, F., el-Sadr, W., Blum, S., Gagliardi, A., Salomon, N. and Turett, G., (1995), Multidrug-resistant TB in patients without HIV infection. N Engl J Med, 333, 907–911.

    PubMed  CAS  Google Scholar 

  • The Inter Departmental Working Group on Tuberculosis, (1998), The Prevention and Control of Tuberculosis in the United Kingdom: UK Guidance on the Prevention and Control of 1) HIV-Related Tuberculosis and 2) Drug Resistant, Including Multiple Drug Resistant, Tuberculosis. Department of Health, The Scottish Office, The Welsh Office, September 1998.

    Google Scholar 

  • Timperi, R, Han, L.L., Sloutsky, A, Becerra, M.C., Nardell, E.A., Salazar, J.J. and Smith, F.M.C., (2005), Drug resistance profiles of Mycobacterium tuberculosis isolates: five years’ experience and insight into treatment strategies for MDR-TB in Lima, Peru. Int J Tuberc Lung Dis, 9, 175–180.

    PubMed  CAS  Google Scholar 

  • Torosyan, A.A., Gurova, A.A. and Mandulova, P.V., (2000), A fifteen-month survey of directly observed therapy—short course and antibiotic drug resistance in the region of Plovdiv. Folia Med, 42, 10–14.

    CAS  Google Scholar 

  • Toungoussova, O.S., Nizovtseva, N.I., Mariandyshev, A.O., Caugant, D.A., Sandven, P. and Bjune, G., (2004), Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999. Eur J Clin Microbiol Infect Dis, 23, 174–179.

    PubMed  CAS  Google Scholar 

  • Trakada, G., Tsiamita, M. and Spiropoulos, K., (2004), Drug-resistance of Mycobacterium tuberculosis in Patras, Greece. Monaldi Arch Chest Dis, 61, 65–70.

    PubMed  CAS  Google Scholar 

  • Tsai, M.S., Chong, I.W., Hwang, J.J., Wang, T.H. and Huang, S.M., (2004), A subset of clinical status of pulmonary tuberculosis in Southern Taiwan. Southeast Asian J Trop Med Pub Hlth, 35, 136–139.

    Google Scholar 

  • Tsogt, G., Naranbat, N., Buyankhisig, B., Batkhuyag, B., Fujiki, A. and Mori, T., (2002), The nationwide tuberculosis drug resistance survey in Mongolia, 1999. Int J Tuberc Lung Dis, 6, 289–294.

    PubMed  CAS  Google Scholar 

  • Tupasi, T.E., Quelapio, M.I.D., Orillaza, R.B., Alcantar, C., Mira, N.R.C., Abeleda, M.R., Belen, V.T., Arnisto, N.M., Rivera, A.B., Grimaldo, E.R., Derilo, J.O., Dimarucut, W., Arabit, M. and Urboda, D., (2003), DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed. Tuberculosis, 83, 52–58.

    PubMed  CAS  Google Scholar 

  • Uplekar, M.W. and Shepard, D.S., (1991), Treatment of tuberculosis by private practitioners in India. Tubercle, 72, 284–290.

    PubMed  CAS  Google Scholar 

  • Vanacore, P., Koehler, B., Carbonara, S., Zacchini, F., Bassetti, D., Antonucci, G., Ippolito, G. and Girardi, E., (2004), Drug-resistant tuberculosis in HIV-infected persons: Italy 1999–2000. Infection, 32, 328–332.

    PubMed  CAS  Google Scholar 

  • van Soolingen, D., Hoogenboezem, T., de Haas P.E.W., Hermans, P.W., Koedam, M.A., Teppema, K.S., Brennan, P.J., Besra, G.S., Portaels, F., Top, J., Schouls, L.M. and Embden, J.D., (1997), A novel pathogen taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol, 47, 1236–1245.

    PubMed  Google Scholar 

  • van Soolingen, D., von der Zanden, A.G.M., de Haas, P.E.W., Noordhoek, G.T., Kiers, A., Foudraine, N.A., Portaels, F., Kolk, A.H.J., Kremer, K. and van Embden, J.D.A., (1998), Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol, 36, 1840–1845.

    PubMed  Google Scholar 

  • Wada, T., Maeda, S., Tamaru, A., Shigeyoshi, L., Hase, A. and Kobayashi, K., (2004), Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol, 42, 5277–5285.

    PubMed  CAS  Google Scholar 

  • World Health Organization, (1997), Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, WHO. WHO/TB/97.220.

    Google Scholar 

  • World Health Organisation Tuberculosis Unit, (1991), Division of Communicable Diseases. Guidelines for Tuberculosis Treatment in Adults and Children in National Tuberculosis Programmes. Geneva, WHO. WHO/TB/91, pp 1–61.

    Google Scholar 

  • World Health Organization, (2004), Anti-tuberculosis Drug Resistance in the World. Report No.3. Geneva, WHO.

    Google Scholar 

  • Yam, W.E., Tem, C.M., Leung, C.C., Tong, L., Chan, K. H., Leung, E.T.Y., Wong, K.C., Yew, W.W., Seto, W.H., Yuen, K. and Ho, P.L., (2004), Direct detection of rifampicin-resistant Mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing. J Clin Microbiol, 42, 4438–4443.

    PubMed  CAS  Google Scholar 

  • Yew, W.W., (2001), Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives. Clin Chim Acta, 313, 31–36.

    PubMed  CAS  Google Scholar 

  • Zaman, K., Rahim, Z., Yunus, M., Arifeen, S., Baqui, A., Sack, D., Hossain, S., Banu, S., Islam, A.M., Ahmed, J., Breiman, R. and Black, R., (2005), Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. Scand J Infect Dis, 37, 21–26.

    PubMed  Google Scholar 

Download references

Authors
  1. Peter D. O. Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Cooke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Infectious Disease, St. Michael’s Hospital, 30 Bond St., Suite 4179 Cardinal Carter Wing, Toronto, Ontario M5B 1W8, Canada

    I. W. Fong (Director) (Director)

  2. International Center for Public Health, 225 Warren Street, Newark, NJ 07103-3535, USA

    Karl Drlica

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Davies, P.D.O., Cooke, R. (2008). Mycobacterial Antimicrobial Resistance. In: Fong, I.W., Drlica, K. (eds) Antimicrobial Resistance and Implications for the Twenty-First Century. Emerging Infectious Diseases of the 21st Century. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72418-8_5

Download citation

Publish with us

Policies and ethics

Search

Navigation